Monaco Asset Management Sam Mirati Therapeutics, Inc. Transaction History

Monaco Asset Management Sam

  • $672 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
SELL
$41.27 - $98.62 $289,509 - $691,819
-7,015 Reduced 41.26%
9,985 $452,000
Q3 2022

Oct 31, 2022
SELL
$59.5 - $86.7 $2.56 Million - $3.73 Million
-43,000 Reduced 71.67%
17,000 $1.19 Million
Q2 2022

Aug 01, 2022
BUY
$39.16 - $88.71 $2.11 Million - $4.79 Million
54,000 Added 900.0%
60,000 $4.03 Million
Q1 2022

May 09, 2022
BUY
$75.82 - $150.97 $454,919 - $905,820
6,000 New
6,000 $493,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email